¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"lateral myocardial infarction"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • central lateral nucleus
    °¡ÂÊÁß½ÉÇÙ, Á߽ɿÜÃøÇÙ
  • lateral
    °¡ÂÊ-, ¿ÜÃø-
  • lateral antebrachial cutaneous nerve
    °¡ÂʾƷ¡ÆÈÇǺνŰæ, ¿ÜÃøÀü¿ÏÇǽŰæ
  • lateral brachial cutaneous nerve
    °¡ÂÊÀ§ÆÈÇǺνŰæ, ¿ÜÃø»ó¿ÏÇǽŰæ
  • lateral canthus
    °¡ÂÊ´«±¸¼®, ¿Ü¾È°¢
  • lateral cerebral fossa
    ´ë³ú°¡ÂÊ¿À¸ñ, ´ë³úÃø¿Í
  • lateral chain
    °ç»ç½½
  • lateral conjugate paralysis
    °¡ÂÊÁֽø¶ºñ, ¿ÜÃøÁֽø¶ºñ
  • lateral corporal fold
    ¸öÅë°¡ÂÊÁÖ¸§
  • lateral corticospinal tract
    °¡ÂʰÑÁúô¼ö·Î, ¿ÜÃøÇÇÁúô¼ö·Î
  • lateral decubitus
    ¿·´©¿ò, Ãø¿ÍÀ§, ¿·´©¿îÀÚ¼¼
  • lateral decubitus position
    ¿·´©¿îÀÚ¼¼, ¸ð·Î´©¿îÀÚ¼¼
  • lateral epicondylitis
    °¡ÂÊÀ§°üÀýÀ¶±â¿°, ¿ÜÃø»ó°ú¿°
  • lateral gastrocnemius bursa
    °¡ÂÊÀåµýÁö±ÙÁÖ¸Ó´Ï, ¿ÜÃøºñº¹±Ù³¶
  • lateral geniculate body
    °¡Âʹ«¸­Ã¼, ¿ÜÃø½½»óü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • myocardial stimulant
    ½É±ÙÀÚ±ØÁ¦, °­½ÉÁ¦
  • myocardial perfusion scintigraphy
    ½É±ÙÁÖ»ç¼ú, ½ÉÀå±ÙÀ°¼¶±¤Á¶¿µ¼ú
  • amyotrophic lateral sclerosis
    ±ÙÀ°À§Ãà°¡ÂʰæÈ­Áõ
  • lateral sacral artery
    °¡ÂʾûÄ¡µ¿¸Æ
  • lateral gastrocnemius bursa
    °¡ÂÊÀåµýÁö±ÙÁÖ¸Ó´Ï
  • lateral maxillary buttress
    °¡ÂÊÀ§ÅλÀ¹öÆÀº®
  • central lateral nucleus
    °¡ÂÊÁß½ÉÇÙ
  • lateral canthus
    °¡ÂÊ´«±¸¼®
  • lateral chain
    (¢¡side chain) °ç»ç½½
  • lateral nasal cartilage
    °¡ÂÊÄÚ¿¬°ñ
  • lateral decubitus
    ¿·´©¿ò, Ãø¿ÍÀ§, ¿·´©¿îÀÚ¼¼
  • lateral cerebral fossa
    ´ë³ú°¡ÂÊ¿À¸ñ
  • lateral corporal fold
    ¸öÅë°¡ÂÊÁÖ¸§
  • retrograde lateral plantar artery flap
    ¿ªÇà°¡Âʹ߹ٴڵ¿¸ÆÇÇÆÇ, ¿ªÇà¿ÜÃøÁ·Àúµ¿¸ÆÇÇÆÇ
  • lateral hermaphroditism
    °¡Âʳ²³àÇѸöÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Lateral muscular branch
    ÄÚ°¡Âʰ¡Áö
  • Lateral palpebral raphe
    °¡ÂÊ´«²¾Íΰó»Æ?
  • Lateral splanchinic arteries
    °¡Âʳ»À嵿¸Æ
  • Lateral tegmental
    ÃøºÎÇǰ³(ö°Ý»ù¬ËÏ)ÀÇ
  • Lateral(part of) globus pallidus
    °¡ÂÊâ¹éÇÙ
  • amyotrophic lateral sclerosis
    ±ÙÀ§Ã༺ Ãø»è °æÈ­Áõ(¡­ö°ßãÌãûùñø).
  • amyotrophic lateral sclerosis
    ±ÙÀ§Ãà¼ºÃø»è°æÈ­Áõ(ÐÉê×õêàõö°ÞþÌãûùñø)
  • anterior dorsal nucleus lateral dorsal nucleus
    ¾ÕµîÂÊÇÙ
  • anterior lateral malleolar artery
    °¡Âʾպ¹»çµ¿¸Æ
  • inclination of lateral condyle path
    Ãø¹æ°ú·Î°æ»ç(µµ)(ö°Û°Î¨ÖØÌËÞØöô).
  • inferior lateral cutaneous nerve of arm
    ¾Æ·¡°¡ÂÊÀ§ÆÈÇǺνŰæ
  • pharyngeal lateral wall
    ÀεÎÃøº®(¡­ö°Ûú).
  • pharyngeal lateral wall
    ÀεÎÃøº®
  • pharyngitis, chronic lateral
    ¸¸¼º¿ÜÃø(¼º) Àεο°
  • pontine lateral reticular nucleus
    ´Ù¸®³ú°¡Âʱ׹°ÇÙ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • atrial infarction
    ½É¹æ°æ»ö(Áõ)(¡­Ìãßáñø).
  • cerebral infarction
    ³ú°æ»ö(ÒàÌÛßá).
  • cerebral infarction
    ³ú°æ»ö(¡­ÌÛßá)
  • coronary infarction
    °ü(»ó)µ¿¸Æ°æ»öÁõ(¡­ÌÛßáñø).
  • infarction
    °æ»ö
  • infarction
    °æ»ö(Áõ)(ÌÛßáñø).
  • infarction
    °æ»öÁõ(ÌÛßáñø)
  • infarction pain
    °æ»öÅë(ÌÛßá÷Ô).
  • infarction,red
    Àû»ö(°æ»ö)(îåßä¡­)
  • infarction,white
    ¹é»ö(°æ»ö)(¹é»ö¡­)
  • interal infarction
    Ãøº®°æ»ö(ö°ÛúÌÛßá).
  • lacunar infarction
    ¿­°ø°æ»öÁõ.
  • liver infarction
    °£°æ»öÁõ(ÊÜÌÛßáñø).
  • lung infarction
    Æó°æ»öÁõ(øËÌãßáñø).
  • mesenteric infarction
    Àå°£¸·°æ»ö(íóÊàØ¯ÌÛßá).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Lateral segment
    °¡Âʱ¸¿ª
    [¿¾ ¿ë¾î] ¿ÜÃø±¸
  • Lateral segment
    °¡Âʱ¸¿ª
    [¿¾ ¿ë¾î] ¿ÜÃøÁß¿±±¸
  • Lateral segmental bronchus
    °¡Âʱ¸¿ª±â°üÁö
    [¿¾ ¿ë¾î] ¿ÜÃøÁß¿±Áö
  • Lateral segmental artery
    °¡Âʱ¸¿ªµ¿¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃø±¸µ¿¸Æ
  • Lateral reticular nucleus
    °¡Âʱ׹°ÇÙ
    [¿¾ ¿ë¾î] ¿ÜÃø¸Á»óüÇÙ
  • Lateral muscular branch
    °¡ÂʱÙÀ°°¡Áö
    [¿¾ ¿ë¾î] ¿ÜÃø±ÙÁö
  • Lateral column
    °¡ÂʱâµÕ
    [¿¾ ¿ë¾î] ÃøÁÖ
  • Lateral column
    °¡ÂʱâµÕ [¿ÜÃø»Ô]
    [¿¾ ¿ë¾î] ÃøÁÖ
  • Lateral pterygoid m.
    °¡Âʳ¯°³±Ù
    [¿¾ ¿ë¾î] ¿ÜÃøÀ͵¹±Ù
  • Lateral pterygoid nerve
    °¡Âʳ¯°³±Ù½Å°æ
    [¿¾ ¿ë¾î] ¿ÜÃøÀ͵¹±Ù½Å°æ
  • Lateral splanchnic arteries
    °¡Âʳ»À嵿¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃø³»À嵿¸Æ
  • Lateral intermuscular septum of thigh
    °¡ÂʳҴٸ®±ÙÀ°»çÀ̸·
    [¿¾ ¿ë¾î] ¿ÜÃø´ëÅð±Ù°£Áß°Ý
  • Lateral femoral cutaneous nerve
    °¡ÂʳҴٸ®ÇǺνŰæ
    [¿¾ ¿ë¾î] ¿ÜÃø´ëÅðÇǽŰæ
  • Lateral femoral circumflex artery
    °¡ÂʳҴٸ®ÈÖµ¹À̵¿¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃø´ëÅðȸ¼±µ¿¸Æ
  • Lateral circumflex femoral vein
    °¡ÂʳҴٸ®ÈÖµ¹ÀÌÁ¤¸Æ
    [¿¾ ¿ë¾î] ¿ÜÃø´ëÅðȸ¼±Á¤¸Æ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • lateral sacrococcygeal ligament
    ¿Ü̵̿¹ÌÀδë
  • lateral semicircular canal
    ¿ÜÃø°ñ¹Ý±Ô°ü, ¿ÜÃø¹Ý±Ô°ü
  • lateral shadow
    ¿ÜÃø±×¸²ÀÚ
  • lateral thoracic artery
    ¿ÜÃøÈ䵿¸Æ
  • lateral tubercle
    ¿ÜÃø°áÀý
  • lateral ventricle
    Ãø³ú½Ç
  • lateral wall echo
    Ãøº®¿¡ÄÚ
  • prominence of lateral semicircular canal
    ¿ÜÃø¹Ý°í¸®°ñ°üÀ¶±â, ¿ÜÃø¹Ý±Ô°üÀ¶±â
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
PI first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;...
AMI Acute Myocardial Infarction
  - Complications(Cx)
    1. Early ...
MI   1) Mitral Insufficient
    = MR
  2) Myocardial Infa...
AWMI anterior wall myocardial infarction
DELIRIUM drugs-electrolytes-low temperature and lunacy-intoxication and intracranial processes-retention of u...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
BIP Bezafibrate Infarction Prevention
CI Cerebral infarction
LI Lacunar infarction
MI Myocardia infarction
MI Postmyocardial infarction
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • combined width of lateral segment tooth
    Ãø¹æ Ä¡±ºÀå
  • deciduous lateral incisor
    À¯ÃøÀýÄ¡
  • inferior lateral pterygoid
    ¿ÜÀ͵¹±Ù ÇϵÎ
  • lateral
    ¿ÜÃø, Ãø¹æ, Ãø¸é, Ãø¹æÀÇ, ¿ÜÃøÀÇ
    ¹Ý´ë¾î=medial. Á¤Á߸éÀ̳ª ½Åü ¶Ç´Â ¹°°ÇÀÇ Á߽ɼ±À¸·ÎºÎÅÍ ¸Ö¾îÁö´Â °Í. ¿·¿¡ ¼ÓÇÑ °Í.
  • lateral abdominal region
    Ãøº¹ºÎ
  • lateral ampullar nerve
    °¡ÂÊ ÆØ´ë ½Å°æ
  • lateral and protrusive excursion
    Ãø¹æ ¹× Àü¹æ Á¢ÃË ¿îµ¿
  • lateral angle of eye
    °¡ÂÊ ´« ±¸¼®
  • lateral anterior malleolar artery
    ¿ÜÀü¹æ Á·±Ù°ú µ¿¸Æ, Àü¿Ü°ú µ¿¸Æ
  • lateral aortic lymph node
    °¡ÂÊ ´ëµ¿¸Æ ¸²ÇÁÀý
  • lateral arcuate ligament
    °¡ÂÊ È°²Ã Àδë
  • lateral atlanto-occipital ligament
    °¡ÂÊ °í¸® µÚÅë¼ö Àδë
  • lateral atlantoaxial articulation
    ¿ÜÃø ȯÃà °üÀý
  • lateral balance training
    Ãø¹æ ¹ë·±½º ÈÆ·Ã
  • lateral basal brach
    °¡ÂÊ ¹Ù´Ú °¡Áö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
myocardial biopsy <procedure> A procedure which involves the removal of a small specimen of cardiac muscle tissue for microscopic analysis.
This is generally performed at the same time as a cardiac catheterisation or as a very similar, yet separate, procedure. A small piece of heart tissue is taken via a small forceps inserted into the cardiac catheter site (usually threaded through a vein in the neck). This test may reveal the cause of a cardiomyopathy, myocarditis, amyloidosis or a heart transplant rejection.
(27 Sep 1997)
myocardial bridge A bridge of cardiac muscle fibres extending over the epicardial aspect of a coronary artery; this finding, in cases of sudden unexpected death, has led to speculation that cardiac contraction during exertion could constrict the coronary artery.
(05 Mar 2000)
myocardial contraction Contractile activity of the heart.
(12 Dec 1998)
myocardial contusion A bruise to the heart muscle, usually caused by a blunt force applied to the anterior thorax (motor vehicle accident). Commonly seen in association with a rib or sternum fracture. Complications include cardiac arrhythmias and death.
(27 Sep 1997)
myocardial depressant factor A low molecular weight peptide of about 800-1000 having a negative inotropic effect. It is released into the circulation during experimental haemorrhagic pancreatitis, severe ischemia, and postoligaemic shock.
(12 Dec 1998)
myocardial diseases Diseases of the myocardium.
(12 Dec 1998)
myocardial infarct imaging <radiology> Tc-99m pyrophosphate (PYP) 20 mCi, peak abnormality 2-3 days, often falsely negative before 2 days, abnormal for 7-10 days, mechanism: calcium influx into ischemic cells, PYP incorporated into crystalline structure, analogous to hydroxyapatite see: nuclear cardiology
(12 Dec 1998)
myocardial insufficiency A condition where there is ineffective pumping of the heart leading to an accumulation of fluid in the lungs. Typical symptoms include shortness of breath with exertion, difficulty breathing when lying flat and leg or ankle swelling. Causes include chronic hypertension, cardiomyopathy and myocardial infarction.
(27 Sep 1997)
myocardial ischemia A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (coronary arteriosclerosis), to obstruction by a thrombus (coronary thrombosis), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (myocardial infarction).
(12 Dec 1998)
myocardial necrosis Irreversible destruction of myocardial (heart muscle) cells.
(27 Sep 1997)
myocardial perfusion imaging <radiology> (thallium scanning) thallium (Tl) 201, acts as potassium analog, dose 2.0 - 3.0 mCi at peak exercise, 4% of injected dose reaches myocardium, imaging: exercise (1-5 min), redistribution (3-4 hrs), views: anterior, LAO 45', left lateral, interpretation: normal, reversible abnormalitymost likely to be exercise-induced ischemia, nonreversible abnormalitymost likely to be prior myocardial infarction, reverse redistribution most likely to be normal areas wash out faster, lung activity most likely to be LV failure during exercise see also: dipyridamole test, nuclear cardiology
(12 Dec 1998)
myocardial reperfusion Generally, restoration of blood supply to heart tissue which is ischemic due to decrease in normal blood supply. The decrease may result from any source including atherosclerotic obstruction, narrowing of the artery, or surgical clamping. Reperfusion can be induced to treat ischemia. Methods include chemical dissolution of an occluding thrombus, administration of vasodilator drugs, angioplasty, catheterization, and artery bypass graft surgery. However, it is thought that reperfusion can itself further damage the ischemic tissue, causing myocardial reperfusion injury.
(12 Dec 1998)
myocardial reperfusion injury Functional, metabolic, or structural changes in ischemic heart muscle thought to result from reperfusion to the ischemic areas. Changes can be fatal to muscle cells and may include oedema with explosive cell swelling and disintegration, sarcolemma disruption, fragmentation of mitochondria, contraction band necrosis, enzyme washout, and calcium overload. Other damage may include haemorrhage and ventricular arrhythmias. One possible mechanism of damage is thought to be oxygen free radicals. Treatment currently includes the introduction of scavengers of oxygen free radicals, and injury is thought to be prevented by warm blood cardioplegic infusion prior to reperfusion.
(12 Dec 1998)
myocardial revascularization The restoration of blood supply to the myocardium.
(12 Dec 1998)
myocardial rigor mortis Irreversible contraction of the left ventricle of the heart as a complication seen in the early period of cardiopulmonary bypass and now avoided by appropriate cardioplegic solutions.
Synonym: myocardial rigor mortis, stone heart.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á